Small-scale production of 67Cu for a preclinical study via the 64Ni( α, p)67Cu channel
In this study, we propose an easy small-scale production of 67Cu using 64Ni target for a preclinical study. (Source: Nuclear Medicine and Biology)
Source: Nuclear Medicine and Biology - February 2, 2018 Category: Nuclear Medicine Authors: Tomoyuki Ohya, Kotaro Nagatsu, Hisashi Suzuki, Masami Fukada, Katsuyuki Minegishi, Masayuki Hanyu, Ming-Rong Zhang Source Type: research
Editorial Board
(Source: Nuclear Medicine and Biology)
Source: Nuclear Medicine and Biology - January 28, 2018 Category: Nuclear Medicine Source Type: research
Table of Contents
(Source: Nuclear Medicine and Biology)
Source: Nuclear Medicine and Biology - January 28, 2018 Category: Nuclear Medicine Source Type: research
90Y radioembolization dosimetry using a simple semi-quantitative method in intrahepatic cholangiocarcinoma: Glass versus resin microspheres
This study aimed to investigate the dose of radiation delivered through glass vs. resin-based 90Y-RE to intrahepatic cholangiocarcinoma (ICC). (Source: Nuclear Medicine and Biology)
Source: Nuclear Medicine and Biology - January 15, 2018 Category: Nuclear Medicine Authors: Nariman Nezami, Nima Kokabi, Juan C. Camacho, David M. Schuster, Minzhi Xing, Hyun S. Kim Source Type: research
Y90 Radioembolization dosimetry using a simple semi-quantitative method in intrahepatic cholangiocarcinoma: Glass versus resin microspheres
This study aimed to investigate the dose of radiation delivered through glass vs. resin-based Y90-RE to intrahepatic cholangiocarcinoma (ICC). (Source: Nuclear Medicine and Biology)
Source: Nuclear Medicine and Biology - January 15, 2018 Category: Nuclear Medicine Authors: Nariman Nezami, Nima Kokabi, Juan C. Camacho, David M. Schuster, Minzhi Xing, Hyun S. Kim Source Type: research
Development of radioiodine labeled acetaminophen for specific, high-contrast imaging of malignant melanoma
In this study, we developed radioiodine labeled acetaminophen (I-AP) for specific, high-contrast imaging of malignant melanoma. (Source: Nuclear Medicine and Biology)
Source: Nuclear Medicine and Biology - January 3, 2018 Category: Nuclear Medicine Authors: Wen Jing Zhu, Masato Kobayashi, Kohei Yamada, Kodai Nishi, Kotaro Takahashi, Asuka Mizutani, Ryuichi Nishii, Leo G. Flores, Naoto Shikano, Munetaka Kunishima, Keiichi Kawai Source Type: research
Development of radioiodine-labeled acetaminophen for specific, high-contrast imaging of malignant melanoma
In this study, we developed radioiodine-labeled acetaminophen (I-AP) for specific, high-contrast imaging of malignant melanoma. (Source: Nuclear Medicine and Biology)
Source: Nuclear Medicine and Biology - January 3, 2018 Category: Nuclear Medicine Authors: Wen Jing Zhu, Masato Kobayashi, Kohei Yamada, Kodai Nishi, Kotaro Takahashi, Asuka Mizutani, Ryuichi Nishii, Leo G. Flores, Naoto Shikano, Munetaka Kunishima, Keiichi Kawai Source Type: research
Synthesis and evaluation of a novel urea-based 68Ga-complex for imaging PSMA binding in tumor
Prostate specific membrane antigen (PSMA) is a well-established target for diagnostic and therapeutic applications for prostate cancer. It is know that [68Ga]PSMA 11 ([68Ga]Glu-NH-CO-NH-Lys(Ahx)-HBED-CC) is the most well studied PET imaging agent for detecting over expressed PSMA binding sites of tumors in humans. In an effort to provide new agents with improved characteristics for PET imaging, we report a novel [68Ga]-Glu-NH-CO-NH-Lys(Ahx)-linker-HBED-CC conjugate with a novel O-(carboxymethyl)-L-tyrosine, as the linker group. (Source: Nuclear Medicine and Biology)
Source: Nuclear Medicine and Biology - December 27, 2017 Category: Nuclear Medicine Authors: Zhihao Zha, Karl Ploessl, Seok Rye Choi, Zehui Wu, Lin Zhu, Hank F. Kung Source Type: research
Imaging of isoproterenol-induced myocardial injury with 18F labeled fluoroglucaric acid in a rat model
The objective of this work was to synthesize 18F –labeled glucaric acid (FGA) for PET imaging of isoproterenol-induced cardiomyopathy in a rat model. (Source: Nuclear Medicine and Biology)
Source: Nuclear Medicine and Biology - December 27, 2017 Category: Nuclear Medicine Authors: Hailey A. Houson, Gregory N. Nkepang, Andria F. Hedrick, Vibhudutta Awasthi Source Type: research
Synthesis and evaluation of a novel urea-based 68Ga-complex for imaging PSMA binding in tumor
Prostate specific membrane antigen (PSMA) is a well-established target for diagnostic and therapeutic applications for prostate cancer. It is know that [68Ga]PSMA 11 ([68Ga]Glu-NH-CO-NH-Lys(Ahx)-HBED-CC) is the most well studied PET imaging agent for detecting over expressed PSMA binding sites of tumors in humans. In an effort to provide new agents with improved characteristics for PET imaging, we report a novel [68Ga]-Glu-NH-CO-NH-Lys(Ahx)-linker-HBED-CC conjugate with a novel O-(carboxymethyl)-L-tyrosine, as the linker group. (Source: Nuclear Medicine and Biology)
Source: Nuclear Medicine and Biology - December 27, 2017 Category: Nuclear Medicine Authors: Zhihao Zha, Karl Ploessl, Seok Rye Choi, Zehui Wu, Lin Zhu, Hank F. Kung Source Type: research
Imaging of isoproterenol-induced myocardial injury with F-18-labeled fluoroglucaric acid in a rat model
The objective of this work was to synthesize 18F –labeled glucaric acid (FGA) for PET imaging of isoproterenol-induced cardiomyopathy in a rat model. (Source: Nuclear Medicine and Biology)
Source: Nuclear Medicine and Biology - December 27, 2017 Category: Nuclear Medicine Authors: Hailey A. Houson, Gregory N. Nkepang, Andria F. Hedrick, Vibhudutta Awasthi Source Type: research
Molecular imaging of platelet-derived growth factor receptor-alpha (PDGFR α) in papillary thyroid cancer using immuno-PET
Receptor tyrosine kinase (RTK) platelet-derived growth factor receptor-alpha (PDGFR α) was recently identified as a molecular switch for dedifferentiation in thyroid cancer that predicts resistance to therapy as well as recurrence of disease in papillary thyroid cancer. Here we describe the radiolabeling and functional characterization of an imaging probe based on a PDGFRα-specif ic monoclonal antibody (mAb) for immuno-PET imaging of PDGFRα in papillary thyroid cancer. (Source: Nuclear Medicine and Biology)
Source: Nuclear Medicine and Biology - December 27, 2017 Category: Nuclear Medicine Authors: Michael Wagner, Melinda Wuest, Ingrit Hamann, Ana Lopez-Campistrous, Todd P.W. McMullen, Frank Wuest Source Type: research
